| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |